Akebia Therapeutics SG&A Expense (TTM) Insights

Akebia Therapeutics, Inc. (AKBA)

1.695 +0.04 (+2.73%) USD | NASDAQ | Dec 24, 12:59

1.695 0.00 (0.00%) After-Hours: 13:52

View SG&A Expense (TTM) for AKBA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (TTM) Chart

Start Trial

View Historical Data

Start Trial

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View SG&A Expense (TTM) Benchmarks

Start Trial

Pfizer Inc.	13.91B
Plus Therapeutics, Inc.	11.09M
Ironwood Pharmaceuticals, Inc.	96.29M
Pyxis Oncology, Inc.	22.04M
Karyopharm Therapeutics, Inc.	109.63M